Cargando…

Calcineurin inhibitors’ impact on cardiovascular and renal function, a descriptive study in lung transplant recipients from the North of Spain

Patients undergoing lung transplantation (LTx) need administration of immunosuppressive therapy following the procedure to prevent graft rejection. However, these drugs are not exempt from potential risks. The development of cardiovascular risk factors and impaired renal function in the post-transpl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nogueiras-Álvarez, Rita, Mora-Cuesta, Víctor Manuel, Cifrián-Martínez, José Manuel, de Cos-Cossío, María Ángeles, García-Sáiz, María del Mar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732215/ https://www.ncbi.nlm.nih.gov/pubmed/36481797 http://dx.doi.org/10.1038/s41598-022-25445-2

Ejemplares similares

Calcineurin inhibitor toxicity in a renal transplant recipient
por: Charney, Douglas A., et al.
Publicado: (2009)

The effect of calcineurin inhibitors on anthropometric measurements in kidney transplant recipients
por: Sayilar, Emel Isiktas, et al.
Publicado: (2022)

Early calcineurin-inhibitor to belatacept conversion in steroid-free kidney transplant recipients
por: Tawhari, Ibrahim, et al.
Publicado: (2022)

Everolimus Based Immunosuppression Strategies in Adult Lung Transplant Recipients: Calcineurin Inhibitor Minimization Versus Calcineurin Inhibitor Elimination
por: Ivulich, Steven, et al.
Publicado: (2023)

Calcineurin Inhibitors in Membranous Nephropathy
por: Ponticelli, Claudio, et al.
Publicado: (2021)

Myeloid-Derived Suppressor Cells Are Increased in Lung Transplant Recipients and Regulated by Immunosuppressive Therapy
por: Iglesias-Escudero, María, et al.
Publicado: (2022)

The Molecular Mechanism of Substrate Engagement and Immunosuppressant Inhibition of Calcineurin
por: Grigoriu, Simina, et al.
Publicado: (2013)

Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical Trial
por: Bredewold, Obbo W., et al.
Publicado: (2022)

Effect of gene polymorphisms on the levels of calcineurin inhibitors in Indian renal transplant recipients
por: Ashavaid, T., et al.
Publicado: (2010)

Calcineurin inhibitors differentially alter the circadian rhythm of T-cell functionality in transplant recipients
por: Leyking, Sarah, et al.
Publicado: (2015)

Pharmacokinetic and Pharmacodynamic Considerations in Relation to Calcineurin Usage in Elderly Kidney Transplant Recipients
por: Cossart, Amelia R., et al.
Publicado: (2021)

The Calcineurin Inhibitor-Sparing (CIS) Trial - individualised calcineurin-inhibitor treatment by immunomonitoring in renal allograft recipients: protocol for a randomised controlled trial
por: Sommerer, Claudia, et al.
Publicado: (2014)

HTLV-1 infection in solid organ transplant donors and recipients in Spain
por: de Mendoza, Carmen, et al.
Publicado: (2019)

Immunosuppression with Calcineurin Inhibitor after Renal Transplant Failure Inhibits Allosensitization
por: López del Moral Cuesta, Covadonga, et al.
Publicado: (2020)

Calcineurin
por: Creamer, Trevor P.
Publicado: (2020)

Newborn screening for Fabry disease in the north-west of Spain
por: Colon, Cristobal, et al.
Publicado: (2017)

Cyclosporine as a preferred calcineurin inhibitor in renal allograft recipients with COVID-19 infection
por: Kemmner, Stephan, et al.
Publicado: (2020)

Invasive haemodynamics in de novo everolimus vs. calcineurin inhibitor heart transplant recipients
por: Bergh, Niklas, et al.
Publicado: (2020)

Calcineurin Inhibitors in Lung Donors to Attenuate Ischemia–Reperfusion Injury in Recipients: Next Steps?
por: Rozenberg, Dmitry, et al.
Publicado: (2022)

Noise Disturbance and Well-Being in the North of Spain
por: Santurtún, Maite, et al.
Publicado: (2022)

Patterns of Diversity and Abundance of Carrion Insect Assemblages in the Natural Park “Hoces del Río Riaza” (Central Spain)
por: Baz, Arturo, et al.
Publicado: (2014)

Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial
por: Cuadrado-Lavín, Antonio, et al.
Publicado: (2020)

Profile of Liver Transplant Recipient in a Tertiary Hospital in Northern Spain
por: Pagnozzi, Janet, et al.
Publicado: (2023)

Description of industrial pollution in Spain
por: García-Pérez, Javier, et al.
Publicado: (2007)

Living at the Wrong Time: Effects of Unmatching Official Time in Portugal and Western Spain
por: Bonmatí-Carrión, María-Ángeles, et al.
Publicado: (2022)

Impact of Extreme Temperatures on Ambulance Dispatches Due to Cardiovascular Causes in North-West Spain
por: Romani, Santiago Gestal, et al.
Publicado: (2020)

Evidence for the Immunosuppressive Potential of Calcineurin Inhibitor-Sparing Regimens in Liver Transplant Recipients with Impaired Renal Function
por: Ide, Kentaro, et al.
Publicado: (2011)

Safety and immunologic benefits of conversion to sirolimus in kidney transplant recipients with long-term exposure to calcineurin inhibitors
por: Yu, Ji Hyun, et al.
Publicado: (2016)

Effect of conversion from calcineurin inhibitors to everolimus on hepatitis C viremia in adult kidney transplant recipients
por: Pacheco, Larissa Sgaria, et al.
Publicado: (2018)

Effect of Calcineurin Inhibitors and Mammalian Target of Rapamycin Inhibitors on the Course of COVID-19 in Kidney Transplant Recipients
por: Hasbal, Nuri Baris, et al.
Publicado: (2021)

An Integrated Transcriptomic Approach to Identify Molecular Markers of Calcineurin Inhibitor Nephrotoxicity in Pediatric Kidney Transplant Recipients
por: Rhone, Erika T., et al.
Publicado: (2021)

Comparison of pregnancy outcomes in Dutch kidney recipients with and without calcineurin inhibitor exposure: a retrospective study
por: Koenjer, Lisanne M., et al.
Publicado: (2021)

Potential interactions between uraemic toxins and drugs: an application in kidney transplant recipients treated with calcineurin inhibitors
por: André, Camille, et al.
Publicado: (2021)

Descriptive Study of Attitudes towards Corporal Expression in Physical Education Students in a Region of Spain
por: Rojo-Ramos, Jorge, et al.
Publicado: (2023)

Pharmacogenomics in clinical trials: an overview
por: Nogueiras-Álvarez, Rita
Publicado: (2023)

Characterization of calcineurin from Cryptococcus humicola and the application of calcineurin in aluminum tolerance
por: Zhang, Lei, et al.
Publicado: (2017)

Bartonella Endocarditis in Spain: Case Reports of 21 Cases
por: García-Álvarez, Lara, et al.
Publicado: (2022)

Long-Term Redistribution of Peripheral Lymphocyte Subpopulations after Switching from Calcineurin to mTOR Inhibitors in Kidney Transplant Recipients
por: Llinàs-Mallol, Laura, et al.
Publicado: (2020)

Prevalence of Burnout Syndrome and Job Satisfaction in Music Therapists in Spain: A Cross-Sectional, Descriptive Study
por: Sequera-Martín, Manuel, et al.
Publicado: (2021)

Genetic structure in the paternal lineages of South East Spain revealed by the analysis of 17 Y-STRs
por: Saiz, María, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nd3h9qlffoui95dpu9k26jmf9e